🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Start Date
2010-10
Trial ID
NCT01228331
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The purpose of this study is to investigate the clinical efficacy of high-d...
Status
Unknown
Location
Department of Hematology, Nagoya University Graduate School of Medicine
Start Date
2002-09
Trial ID
NCT00131027
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
The study evaluates the efficacy and tolerability of an intensified inducti...
Status
Completed
Location
University of Frankfurt, Medical Dept. II
Start Date
2003-04
Trial ID
NCT00198991
The purpose of this trial was to evaluate efficacy and safety of adding Rit...
Status
Completed
Location
Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo
Start Date
2002-06
Trial ID
NCT00556127
This study has been designed to evaluate whether "anti-angiogenesis" therap...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
1998-08
Trial ID
NCT00083551
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested